Unerwartete Komplikationen während des Entzugs vom Research Chemical AH-7921
| Autor: | V. Blaas, J. Thome, A. Bernius, D. Rentsch, A. Büttner |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Bradycardia business.industry Urinary retention AH-7921 Research chemical 03 medical and health sciences Psychiatry and Mental health 030104 developmental biology 0302 clinical medicine Neurology Anesthesia Medicine Neurology (clinical) Epileptic seizure Young adult medicine.symptom business 030217 neurology & neurosurgery Young male medicine.drug Buprenorphine |
| Zdroj: | Fortschritte der Neurologie · Psychiatrie. 84:S80-S83 |
| ISSN: | 1439-3522 0720-4299 |
| DOI: | 10.1055/s-0042-113960 |
| Popis: | We describe the case of a young male patient who had consumed the morphine-like substance AH-7921 which is available via the internet. He was initially admitted to hospital because of obstipation and presented within a day of inpatient treatment for the first time with a generalized tonic-clonic epileptic seizure with subsequent urinary retention. Within a few hours, the patient then also developed bradycardia, while at the same time describing symptoms of physical opioid withdrawal which gradually deteriorated within the following hours. We initiated a treatment with buprenorphine which resulted in a considerable reduction of withdrawal symptoms, so the patient could be discharged from hospital. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|